Treatment Patterns and Outcomes of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in Tanzania

Treatment Patterns and Outcomes of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in Tanzania

PURPOSEHuman epidermal growth factor receptor 2 (HER2)–positive breast cancer (HER2+BC) is linked to poorer outcomes. Trastuzumab is the standard treatment, but its high cost limits access in resource-limited settings. This study evaluated the treatment patterns and survival outcomes of patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Lemi Ndugumbi Zinga, Queen Godfrey Tarimo, Kelvin Mbelekwa, Mamsau Twalib Ngoma, Emmanuel L. Lugina
Format: Article
Language:English
Published: American Society of Clinical Oncology 2025-08-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO-24-00612
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items